Also on this list
WellMedR
The $49 and $89 "Monthly Plan" cards are 12-month rates; monthly is $99 or $129.
Another provider on our brand-name GLP-1 provider ranking.
Read the WellMedR review →
Provider review
Maximus lists sermorelin at $299.99/mo, tirzepatide at $249.99/mo (2-mo prepay) and Brand-name GLP-1 at From $299.99/mo (advertised as $199.99 first month). Prices checked October 2026.
Compounded tirzepatide has no monthly plan: the shortest is two months, paid up front.
Maximus sells compounded tirzepatide only on prepaid plans of 2, 4, 6 or 12 months. The $149.99/mo on its pages is the 12-month rate ($1,799.88 up front); the shortest plan is $249.99/mo, billed $499.98 every two months. Compounded semaglutide is no longer offered.
Transparency scorecard
1 of 4 disclosed openly
What Maximus discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
States no federal regulatory category (503A/503B) for its pharmacy on its own site.
State coverage published
Not disclosed
Its own pages give state lists that disagree — confirm your state during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit MaximusPharmacy
Not categorized
Labs
Not required for sermorelin; not stated for tirzepatide.
States
Lists disagree
Also on this list
WellMedR
The $49 and $89 "Monthly Plan" cards are 12-month rates; monthly is $99 or $129.
Another provider on our brand-name GLP-1 provider ranking.
Read the WellMedR review →| Compound | Advertised | What you pay monthly | Pharmacy | Checked |
|---|---|---|---|---|
| Sermorelin | $299.99/mo | $299.99/mo | Not disclosed | October 2026 |
| Tirzepatide | $250/mo on a 2-mo prepay | $249.99/mo (2-mo prepay) | Not disclosed | October 2026 |
| Brand-name GLP-1 | $199.99 first month | From $299.99/moHigher than advertised | Not disclosed | October 2026 |
What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not required
Coaching
Not confirmed
The catch — Each "starting at" figure is a longer plan or a first month: tirzepatide's $149.99 is the 12-month rate, sermorelin's $199.99 is the 6-month rate, and the brand-name pages show the price after a $100 first-month discount that checkout applies on its own. Its intake opens with yet another figure, "$179 starting at /mo."
See plans at MaximusPrices read from Maximus's own site
What they advertise
Tirzepatide "$149.99/mo on the 12-month plan"; Sermorelin "starting at $199.99/mo"; Foundayo "Starting at $199.99/mo."
What you actually pay
Tirzepatide: $249.99/mo on the shortest plan, billed $499.98 every two months; $219.99/mo on 4 months, $199.99/mo on 6 months ($1,199.94) and $149.99/mo on 12 months ($1,799.88), the same at every dose. Sermorelin: $299.99/mo for one month, $274.99/mo on a 2-month plan, $199.99/mo on a 6-month plan. Brand-name, month to month: Foundayo $299.99/mo at the lowest dose (up to $499.99 at 17.2 mg), the Wegovy pill from $349.99, Wegovy pens from $449.99, Zepbound from $549.99.
Money you will meet later
Maximus (legal entity Maximus Health, Inc.) is a large telehealth company for testosterone, GLP-1 weight loss and growth-hormone peptides. It sells compounded tirzepatide, compounded sermorelin and six brand-name GLP-1s; compounded semaglutide is gone from its weight-loss menu.
Maximus appears on our sermorelin provider ranking, our tirzepatide provider ranking, our brand-name GLP-1 provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Maximus states no 503A/503B category for the pharmacy that fills your prescription.
Unknown. It says only that it works with "US-based, fully licensed compounding pharmacies" that are LegitScript-certified; no pharmacy is named and no category is stated.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Tirzepatide: "all states but AL, MS, LA," per its product FAQ, though its company-information page says GLP-1 programs reach all 50 states and DC. Sermorelin: "all states except Alabama."
The part they would rather you skipped
Compounded tirzepatide cannot be bought one month at a time. Every plan is prepaid, the shortest is two months ($499.98), and its checkout refund policy gives no refund on a multi-month plan once the first month's supply arrives; changes need 48 hours' notice before the next processing date. The headline prices on its pages are longer-plan or first-month rates, and its company-information page still lists a semaglutide protocol and all-50-state GLP-1 coverage that its product pages and intake no longer show. A live FDA warning letter is on record: Maximus Health, Inc. dba Maximus, MARCS-CMS 730095, June 8, 2026, for claims ("Clinically studied ingredients," "Proven to lose weight effectively") implying FDA evaluation, plus a false "FDA approved pharmacies" claim FDA directly rejects ("Compounding facilities... are not 'FDA-approved' or 'FDA-licensed' entities"). None of those phrases is on its current product pages.
Other providers on our brand-name GLP-1 provider ranking — the closest match to what Maximus sells.



11 more providers are on our brand-name GLP-1 provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Ready to get started?
Prices and plans in this category change often — check Maximus's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Maximus's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Maximus's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Maximus
3 compounds from $249.99/mo (2-mo prepay)